<DOC>
	<DOCNO>NCT02324556</DOCNO>
	<brief_summary>All patient plan anterior resection due rectal cancer total mesorectal excision include . This feasibility study , thus randomization perform . Primary endpoint clinical pathologic examination specimen . Secondary end-points include clinical variable conversion rate , re-admission and/or re-operation due complication health economy analysis .</brief_summary>
	<brief_title>A LAparoscopic TransAnal Total Mesorectal Excision ( TME ) Rectal Cancer Trial</brief_title>
	<detailed_description>The design comparative prospective , compare specimens patient operate institution last year standard open laparoscopic approach patient operate new technique . Patients control arm patient operate prior commencement new technique patient eligible possible include study . It possible obtain macroscopically microscopically adequate specimen combine approach laparoscopic transanal TME compare open laparoscopic conventional TME .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>present rectal cancer possible operate total mesorectal excision anastomosis accord local multidisciplinary conference possible operate laparoscopic technique possible operate regard concomitant disease give informed consent participate Participation trial conflict protocol endpoint LATAtrial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rectal Cancer</keyword>
	<keyword>Surgery</keyword>
	<keyword>Laparoscopy</keyword>
</DOC>